Worldwide industrial services company Harsco Corp. last week said its SGB access services division has been awarded two contracts totaling more than $1.6 million to support construction of a new GlaxoSmithKline Vaccine Plant in Singapore.
The new contracts underscore the accelerating growth of SGB’s branch operations in Singapore as one of the country’s Ieading access services and rental equipment suppliers and a major player in some of Singapore’s most prestigious construction projects. The new plant is GSK’s biggest vaccine investment in Asia and will be the first such facility in Singapore, fast becoming a major world center for biotechnology and pharmaceutical production.
Growth in the Asia-Pacific sector is one of the cornerstones of Harsco’s strategic objectives for increasing stockholder value through an expanded presence in the world’s developing economies, including Eastern Europe, Latin America, the Middle East and Africa. Harsco’s international footprint in 45 countries accounted for more than 60 percent of the company’s 2006 revenues and nearly 70 percent in the most recent quarter.
The SGB division is part of Harrisburg, Pa.-based Harsco’s global Access Services business group. The company’s North America-based Patent division is No. 18 on the RER 100.
